ADC Therapeutics SA — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/60f34fc8-e985-4330-b278-ca3bb1bc2f84/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $81.4M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-016491 |
| FY 2024 | $70.8M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-015131 |
| FY 2023 | $69.6M | 2023-01-01 – 2023-12-31 | evidence 0001628280-25-015131 |
| FY 2022 | $74.9M | 2022-01-01 – 2022-12-31 | evidence 0001628280-24-010843 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ADC Therapeutics SA — all facts · Net Income · Operating Income